Zielgruppe

Scientists from academia and industry, formulation experts, managers in pharmaceutical research and development, production, quality assurance, project management, product management and life cycle management.

Zielsetzung

Over the last two decades the number of oral drug candidates in discovery and development, which are poorly water soluble, and thus show poor bioavailability, has tremendously increased. In parallel, expertise was developed on how to overcome this challenge and many different technologies have been discovered. This makes it quite difficult for a formulation scientist nowadays to get or keep the overview including all pros and cons of the respective approaches ready to hand in order to select the appropriate one for a specific molecule. This two day conference will provide you with an insight into human physiology and its implications to poorly soluble compounds, introduce you to the most important technologies used, but also mention emerging approaches and of course present you a summary of commercial products and the formulation approaches applied.